Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosis by Figueiredo, L et al.
© UEG. 2018 
Presentation by 
Risk factors for the emergence of multidrug-
resistant organisms in liver cirrhosis 
22/10/2018 
Luísa Martins Figueiredo 
Hospital Professor Doutor Fernando Fonseca | Portugal 
 
Figueiredo LM; Rafael MA; Alexandrino G; Martins A; Oliveira A; 
Carvalho R; Santos L; Horta D; Lourenço L; Reis J; Costa M  
Hospital Professor Doutor Fernando Fonseca 











Infections in patients with liver cirrhosis (LC) are common. 
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Jalan R et al Bacterial infections in cirrhosis Journal of Hepatology 2014; Piano S et al 
Infections complicating cirrhosis Liver International. 2018 
 
Infections are present at admission 
or develop during hospitalization in 
25–35% of patients (4–5 fold higher 
compared with general population) 
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Multidrug resistant organisms (MDROs) are bacteria resistant to 3 or more of the 
main antibiotic families.  
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Jalan R et al Bacterial infections in cirrhosis: A position statement based 
on the EASL Special Conference 2013 Journal of Hepatology 2014; 











ESBL: extended spectrum beta lactamase 
producing Enterobacteriaceae 
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Introduction 
Overall mortality of infected 
cirrhotic patients is around 
30% at 1 month and more 
than 50% at 12 months 
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Bartoletti M, et al Opportunistic infections in end stage liver disease Infectious Disease Reports 2017; Marcus M et al Bacterial infection- 
triggered acute-on-chronic liver failure is associated with increased mortality L International. 2017 
Liver cirrhosis is the 10th most common cause of death in Western world. 
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Ferrarese A et al Management of bacterial infection in the liver 
transplant candidate World J Hepatol  2018 
Viale P, Decompensated cirrhosis Infections in cirrhotic patient viale 
The International Liver congress 2017 EASL Postgraduated course 
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Research on risk factors of bacterial infections in cirrhosis. 
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Methods 
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 Prospective study from October 2017 to March 2018 
 Consecutively hospitalized patients with decompensated LC with infection  
 Blood, urine and ascitic fluid cultures were analysed 
 Statistical significance: p-value <0.0500 
Aim 
Identify risk factors for the occurrence of MDROs in patients with LC. 
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Patients Analysis 
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Age 
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Patients Analysis 
Number of isolated microorganisms identified 
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 MDROs identified: Klebsiella 
ESBL, E. faecium, E. Faecalis, 
MRSA, KPC, Clostridium dificile, 
Staphylococcus haemolyticus 
methicillin resistant 
 Klebsiella ESBL was the most 

















MDROs were significantly associated with: 
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There was no MDROs relevant statistical association with: 
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Conclusion 
 MDROs are a current reality that can alter the paradigm of treatment and 
prevention of infection in LC. 
 The indiscriminate use of antibiotics and PPIs increases the risk of MDROs 
infections, suggesting that the prescription of these drugs should be restricted to formal 
indication. 
 Hospitalization for more than 48 hours or hospital discharge for less than 30 days 
have been shown to influence the onset of MDROs, suggesting that hospitalizations 
in LC patients should be limited to the minimum number of days required. 
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